Comprehensively, our results indicate that susceptibility to CHDs in patients with DS is influenced by common genetic variation (SNPs) of genes coding for IFN receptor mapping on critical regions of HSA21 and by genes located on other chromosomes, such as VEGFA. This evidence concerns the gene VEGFA and Dravet syndrome.